Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas.
Eisenhardt AE, Schmid A, Esser J, Brugger Z, Lausch U, Kiefer J, Braig M, Runkel A, Wehrle J, Claus R, Bronsert P, Leithner A, Liegl-Atzwanger B, Zeller J, Papini R, von Laffert M, Pfitzner BM, Koulaxouzidis G, Giunta RE, Eisenhardt SU, Braig D.
Eisenhardt AE, et al. Among authors: koulaxouzidis g.
Mol Cancer. 2022 Feb 14;21(1):50. doi: 10.1186/s12943-022-01523-x.
Mol Cancer. 2022.
PMID: 35164780
Free PMC article.
No abstract available.